Maynard Um
-
-
-
-
-
-
-
Raymond James sees potential for beats across biopharma coverage
-
-
-
-
-
-
-
Tonix Pharma (TNXP) Misses Q1 EPS by 35c
-
-
-
-
-
-
-
Tonix Pharmaceuticals moves to NASDAQ Global Select Market
-
-
-
-
-
-
-
Tonix presents TNX-1500 data at Japan transplantation congress
-
-
-
-
-
-
-
Tonix Pharma (TNXP) Tops Q2 EPS by 297c
-
-
-
-
-
-
-
Tonix Pharma (TNXP) Tops Q1 EPS by 284c
-
-
-
-
-
-
-
Tonix Pharma (TNXP) Announces that FDA Will Not Require an Advisory Committee Meeting to Discuss New Drug Application for TNX-102 SL
-
457,209 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

